Sumitomo Pharma Co., Ltd.
SMDPY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $20 | $23 | $85 |
| Short-Term Investments | $0 | $0 | $17 | $0 |
| Receivables | $1 | $83 | $75 | $94 |
| Inventory | $1 | $90 | $94 | $107 |
| Other Curr. Assets | $0 | $63 | $44 | $47 |
| Total Curr. Assets | $2 | $257 | $253 | $334 |
| Property Plant & Equip (Net) | $0 | $46 | $47 | $53 |
| Goodwill | $1 | $191 | $197 | $209 |
| Intangibles | $1 | $165 | $173 | $194 |
| Long-Term Investments | $1 | $7 | $72 | $0 |
| Tax Assets | $0 | $0 | $1 | $0 |
| Other NC Assets | $0 | $67 | $0 | $63 |
| Total NC Assets | $3 | $477 | $489 | $518 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5 | $733 | $743 | $852 |
| Liabilities | – | – | – | – |
| Payables | $0 | $39 | $39 | $49 |
| Short-Term Debt | $0 | $50 | $46 | $255 |
| Tax Payable | $0 | $0 | $2 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $142 | $154 | $195 |
| Total Curr. Liab. | $1 | $232 | $241 | $499 |
| LT Debt | $2 | $259 | $259 | $119 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $27 | $0 |
| Other NC Liab. | $0 | $66 | $47 | $67 |
| Total NC Liab. | $2 | $325 | $333 | $187 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $9 | $0 |
| Total Liabilities | $3 | $557 | $573 | $686 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $22 | $22 | $22 |
| Retained Earnings | $1 | $58 | $47 | $42 |
| AOCI | $1 | $97 | $101 | $103 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $2 | $176 | $169 | $166 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5 | $733 | $743 | $852 |
| Net Debt | $2 | $289 | $282 | $289 |